Old Web
English
Sign In
Acemap
>
authorDetail
>
Xing Zeng
Xing Zeng
University of Kansas
Prostate cancer
Cancer research
Prodrug
Androgen receptor
Cancer
3
Papers
94
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Cav1.3 channel α1D protein is overexpressed and modulates androgen receptor transactivation in prostate cancers1
2014
Urologic Oncology-seminars and Original Investigations
Ruibao Chen
Xing Zeng
Ruitao Zhang
Jiaoti Huang
Xiangxing Kuang
Jun Yang
Jihong Liu
Ossama Tawfik
James Brantley Thrasher
Benyi Li
Show All
Source
Cite
Save
Citations (50)
795 PROSTATE CANCER-TARGETED DELIVERY OF NANOMICELLE-LOADED WITH P110BETA-SPECIFIC INHIBITOR TGX221 PRO-DRUGS SUPPRESSES XENOGRAFT TUMOR GROWTH
2013
The Journal of Urology
Zachary Hamilton
Xing Zeng
Ruibao Chen
Yunqi Zhao
Qiuhong Yang
Yan Huang
Laird Forrest
J. Brantley Thrasher
Benyi Li
Show All
Source
Cite
Save
Citations (0)
Prodrug strategy for PSMA-targeted delivery of TGX-221 to prostate cancer cells.
2012
Molecular Pharmaceutics
Yunqi Zhao
Shaofeng Duan
Xing Zeng
Chunjing Liu
Neal M. Davies
Benyi Li
M. Laird Forrest
Show All
Source
Cite
Save
Citations (44)
1